Older Moms’ Estrogen Pill Carries Blood Clot Risk: CDC Report

pills_30

Thirdage.com

Posted by Sheila Ring on July 11, 2011 9:44 AM

Older moms’ estrogen pills should be avoided, the Centers for Disease Control and Prevention (CDC) has warned, after it found they can raise the risk of blood clots.

’1 in 20 women’ hit by early menopause: Doctors baffled at rising numbers of under-40s affected

menopause2

Mail Online
United Kingdom

By Jenny Hope
Last updated at 7:42 AM on 7th July 2011

More than one in 20 women go through an early menopause which puts them at greater risk of heart attack, stroke and bone disease in later life, warn researchers.

Higher than expected numbers stop having periods before the age of 40 for no known medical reason, a study has found.

Concern rising over pollutants in waters

FeminizedFish-710365

StarTribune

Article by: ANDREW MONSERUD , St. Paul Academy
Updated: July 4, 2011 – 11:32 PM

Minnesotans are pretty confident about their water. After all, we have the source of the Mighty Mississippi and more than 14,000 lakes. Why should we worry about water?

But some Minnesotans are worried, and for good reason. Scientists are increasingly aware of pollutants that were unknown or immeasurable just a few years ago. One documented effect has been the “feminization” of fish in the Mississippi River because of estrogen-like chemicals in the water.

Pfizer’s Bid to Appeal $58 Million Prempro Jury Award Denied

Bloomberg

By Greg Stohr and Jef Feeley -
Jun 20, 2011 10:01 AM MT

The U.S. Supreme Court refused to hear a Pfizer Inc. (PFE) unit’s appeal of a $58 million award to three Nevada women who contracted breast cancer after taking the company’s Premarin and Prempro menopause drugs.

Pfizer Sets Aside $772 Million, Settles One-Third of Prempro Drug Cases

Bloomberg

By Jef Feeley – May 12, 2011 9:01 PM MT

Pfizer Inc. (PFE), which has settled a third of the pending cases over its Prempro menopause drug, said it set aside $772 million to resolve claims the medicine causes breast cancer.

Integrative approaches to menopause

chiroeco.com

Sharpen your understanding of hormonal balancing and estrogen level management.

By Debra Muth, ND, RN, WHNP, BAAHP
May 13, 2011

The transition to menopause can be a time of reflection and inspiration. Although transitions of any kind can be inherently difficult, many women experience a newfound sense of freedom and personal growth during menopause. As one author put it: “Menopause is a time of great change — it is the adolescence of older age but better than the adolescence of youth because menopausal women have confidence and experience.”

Female Patients Translate into Huge Possibilities for the Bottom Line

Mercola.com

Excerpted from:
My New Warning: Avoid THESE Medical Treatments Whenever Possible
Posted By Dr. Mercola | May 09 2011

Women stand the greatest risk of receiving an unnecessary medical procedure. If you are a female living in the US, when it comes to healthcare, you might as well have a target on your back.

Drugging America: The drug industry exposed

Washington Times

March 27, 2011

Washington D.C., March 27, 2011 – Pharmaceuticals are a $650 plus billion dollar a year industry. For years the most profitable business in the U.S. has been the pharmaceutical corporations, which routinely top the annual fortune 500 list. Doctor prescribed drugs support an industry which out-earns the GNP of many nations.

Pfizer Agrees to Settle Prempro Lawsuits

AVVO February 11, 2011 Drugmaker Pfizer Incorporated has agreed to settle more than 2,200 lawsuits filed against its Wyeth unit over its hormone replacement drug Prempro. A company spokesman told Bloomberg News that Pfizer will pay $330 million over claims that Prempro caused breast cancer. More than 6 million women reportedly took the drug, which Continue Reading …

Bio-identical hormone therapy raising flags

CBC News
Canada

Last Updated: Friday, February 11, 2011 | 12:13 PM ET

Some doctors in Canada are warning women that they are courting risks they may not even be aware of when they turn to bio-identical hormone replacement therapy to treat the symptoms of menopause.